|
Volumn 349, Issue 9048, 1997, Pages
|
CAPRIE trial.
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
CLOPIDOGREL;
DRUG DERIVATIVE;
TICLOPIDINE;
DIPYRIDAMOLE;
BRAIN ISCHEMIA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG COST;
ECONOMICS;
HUMAN;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
CEREBROVASCULAR DISEASE;
COMPARATIVE STUDY;
COST BENEFIT ANALYSIS;
TREATMENT OUTCOME;
ASPIRIN;
BRAIN ISCHEMIA;
DRUG COSTS;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
RANDOMIZED CONTROLLED TRIALS;
TICLOPIDINE;
CEREBROVASCULAR DISORDERS;
COST-BENEFIT ANALYSIS;
DIPYRIDAMOLE;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 0031065631
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/s0140-6736(05)62851-6 Document Type: Note |
Times cited : (12)
|
References (0)
|